4//SEC Filing
Thorp Clay 4
Accession 0001209191-23-050480
CIK 0001539029other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:34 PM ET
Size
6.9 KB
Accession
0001209191-23-050480
Insider Transaction Report
Form 4
Thorp Clay
Director
Transactions
- Purchase
Common Stock
2023-09-25$0.86/sh+10,000$8,600→ 40,522 total
Holdings
- 3,545,040(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8549 to $0.8595 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The Reporting Person is one of the general partners of: (i) Hatteras Venture Advisors III, LLC, the general partner of HVP III and HVA III; (ii) Hatteras Venture Advisors IV SBIC, LLC, the general partner of HVP IV SBIC; and (iii) Hatteras Venture Advisors IV, LLC, the general partner of Hatteras Venture Partners IV, LP ("HVP IV") and Hatteras NC Fund, LP ("Hatteras NC"). HVP III, HVA III, HVP IV SBIC, HVP IV and Hatteras NC are the record holders of the securities, and the reporting person may be deemed to share voting and dispositive power over the securities held by HVP III, HVA III, HVP IV SBIC, HVP IV and Hatteras NC.
- [F3]The Reporting Person disclaims beneficial ownership of these securities and this report is not an admission that the reporting person is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001592380
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 4:34 PM ET
- Size
- 6.9 KB